By , STOCKHOLM (Reuters) - A Swedish study found that just 7.3 percent of Stockholmers developed COVID-19 antibodies by late April, which could fuel concern that a decision not to lock down Sweden against the pandemic may bring little herd immunity in the near future.The strategy was championed by Chief Epidemiologist Anders Tegnell, whose recommendation for voluntary measures against the virus, rather than a mandatory lockdown like those imposed by many other countries, has divided opinion at home and abroad.Sweden’s strategy of keeping most schools, restaurants, bars and businesses open...…By , STOCKHOLM (Reuters) - A Swedish study found that just 7.3 percent of Stockholmers developed COVID-19 antibodies by late April, which could fuel concern that a decision not to lock down Sweden against the pandemic may bring little herd immunity in the near future.The strategy was championed by Chief Epidemiologist Anders Tegnell, whose recommendation for voluntary measures against the virus, rather than a mandatory lockdown like those imposed by many other countries, has divided opinion at home and abroad.Sweden’s strategy of keeping most schools, restaurants, bars and businesses open...WW…

By , , STOCKHOLM/BERLIN (Reuters) - Two scientists won the 2020 Nobel Prize in Chemistry on Wednesday for creating genetic ‘scissors’ that can rewrite the code of life, contributing to new cancer therapies and holding out the prospect of curing hereditary diseases.Emmanuelle Charpentier, who is French, and American Jennifer Doudna share the 10 million Swedish crown ($1.1 million) prize for developing the CRISPR/Cas9 tool to edit the DNA of animals, plants and microorganisms with precision.“The ability to cut the DNA where you want has revolutionized the life sciences,” Pernilla Wittung...…By , , STOCKHOLM/BERLIN (Reuters) - Two scientists won the 2020 Nobel Prize in Chemistry on Wednesday for creating genetic ‘scissors’ that can rewrite the code of life, contributing to new cancer therapies and holding out the prospect of curing hereditary diseases.Emmanuelle Charpentier, who is French, and American Jennifer Doudna share the 10 million Swedish crown ($1.1 million) prize for developing the CRISPR/Cas9 tool to edit the DNA of animals, plants and microorganisms with precision.“The ability to cut the DNA where you want has revolutionized the life sciences,” Pernilla Wittung...WW…